U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07399210) titled 'Noninvasive Detection of Lung Nodule Malignancy Using cfDNA Fragmentomics' on Aug. 10, 2025.
Brief Summary: The goal of this observational study is to learn if cfDNA fragmentomics can noninvasively diagnose whether lung nodules are benign or malignant in adults with imaging-detected lung nodules.
Study Start Date: Aug. 21, 2024
Study Type: OBSERVATIONAL
Condition:
Lung Cancer (Diagnosis)
Fragmentomics
Intervention:
OTHER: This study did not include intervention between two cohorts
This study did not include intervention between two cohorts
Recruitment Status: RECRUITING
Sponsor: Baohui Han
Information provided by (Responsi...